Internal Medicine, Nephrology · Statesboro, GA
NPI
1124119219
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1030 Bermuda Run
Statesboro, GA, 30458
Phone (912) 764-8396
Groups this clinician bills Medicare through
Medicare paid, 2024
$366K
3,864 services
Medicare patients, 2024
473
Average age 74
Drug cost, 2024
$1.6M
7,978 prescriptions
Company payments, 2025
$3,117
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Courage A Atekha was code 99232 (hospital e&m - subsequent), 1,105 times for 133 patients. In total Courage A Atekha billed 3,864 services in 23 codes, and Medicare paid $366K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,105 | 133 | $61.33 | $68K |
| 99214 Office E&M - Established | Office | 589 | 244 | $90.66 | $53K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 443 | 250 | $12.78 | $5,662 |
| 90960 ESRD Related Services (not dialysis) | Office | 405 | 59 | $267.45 | $108K |
| 99233 Hospital E&M - Subsequent | Facility | 294 | 152 | $92.25 | $27K |
| 99223 Hospital E&M - Initial | Facility | 290 | 160 | $134.71 | $39K |
| 99213 Office E&M - Established | Office | 205 | 140 | $62.62 | $13K |
| 90961 ESRD Related Services (not dialysis) | Office | 93 | 48 | $225.81 | $21K |
| 90966 ESRD Related Services (not dialysis) | Office | 72 | 12 | $225.90 | $16K |
| 99205 Office E&M - New | Office | 43 | 43 | $147.74 | $6,353 |
By year: 2022 $450K for 3,771 services; 2023 $382K for 3,242 services; 2024 $366K for 3,864 services.
Medicare prescription drug claims, 2024
In 2024, the drug Courage A Atekha prescribed most often to Medicare patients was Losartan Potassium, with 469 prescriptions and refills. In total Courage A Atekha wrote 7,978 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 469 | 965 | 130 | $3,034 |
| Amlodipine Besylate Generic | 350 | 729 | 95 | $1,313 |
| Sevelamer Carbonate Generic | 345 | 463 | 86 | $52K |
| Calcitriol Generic | 327 | 647 | 79 | $5,677 |
| Farxiga Dapagliflozin Propanediol | 324 | 481 | 74 | $266K |
| Furosemide Generic | 315 | 508 | 80 | $1,186 |
| Jardiance Empagliflozin | 293 | 413 | 60 | $248K |
| Carvedilol Generic | 263 | 486 | 73 | $1,809 |
| Rayaldee Calcifediol | 244 | 268 | 37 | $338K |
| Atorvastatin Calcium Generic | 223 | 491 | 62 | $1,214 |
| Potassium Chloride Generic | 214 | 347 | 49 | $2,466 |
| Hydralazine Hcl Generic | 209 | 331 | 47 | $1,613 |
| Kerendia Finerenone | 184 | 244 | 33 | $160K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 167 | 373 | 42 | $1,563 |
| Allopurinol Generic | 156 | 316 | 32 | $954 |
Brand drugs: 1,633 claims; generic drugs: 6,322 claims; opioid claims: 164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Courage A Atekha $3,117 ($1,555 in general payments such as food, travel and fees and $1,562 for research) from 12 companies. The largest payer was CSL Behring with $1,562.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 1 | $1,562 |
| Ardelyx, Inc. ARDX | 10 | $295 |
| Amgen Inc. AMGN | 7 | $228 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 8 | $206 |
| Travere Therapeutics, Inc. TVTX | 9 | $173 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $171 |
| Calliditas Therapeutics US Inc. | 6 | $161 |
| OPKO Pharmaceuticals, LLC | 4 | $89.68 |
| Novo Nordisk Inc NVO | 4 | $83.69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.